A multicenter, phase III, randomised study of photodynamic therapy with Metvix cream [methyl aminolevulinate] 160 mg/g in comparison with cryotherapy in patients with primary superficial basal cell carcinoma.
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2010
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- Sponsors PhotoCure
- 01 Oct 2008 Results have been published in the European Journal of Dermatology.
- 11 Jul 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History